site stats

Bluebird bio sec filings

WebApr 14, 2024 · The firm owned 5,924 shares of the basic materials company’s stock after buying an additional 1,370 shares during the quarter. IFG Advisory LLC’s holdings in Celanese were worth $605,000 as of its most recent SEC filing. Other institutional investors and hedge funds have also recently bought and sold shares of the company. WebAug 9, 2024 · CAMBRIDGE, Mass. – August 9, 2024 – bluebird bio, Inc. (NASDAQ: BLUE) today reported financial results and business highlights for the second quarter ended June 30, 2024 and provided operational updates, including the announcement that the U.S. Food and Drug Administration (FDA) placed a clinical hold on clinical studies of elivaldogene …

bluebird bio - BLUE Stock Forecast, Price & News - MarketBeat

WebMay 21, 2024 · On May 21, 2024, bluebird bio, Inc. (“bluebird”) issued a press release to announce that it received a positive opinion recommending marketing authorization from the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) for SKYSONA™ (elivaldogene autotemcel, Lenti-D™), a one-time gene … WebDec 31, 2024 · Media Contacts. Jess Rowlands. Head of Corporate Communications (857) 299-6103. [email protected]. Investor Contacts. Courtney O’Leary. … rony cherfan https://druidamusic.com

IFG Advisory LLC Has $605,000 Holdings in Celanese Co. (NYSE:CE)

WebJul 21, 2024 · Bluebird Bio, Inc. Nov. 6, 2024 Downloads WebApr 14, 2024 · Cookson Peirce & Co. Inc. purchased a new position in bluebird bio, Inc. (NASDAQ:BLUE – Get Rating) during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm purchased 10,000 shares of the biotechnology company’s stock, valued at approximately $69,000. Several other … WebMar 15, 2024 · SEC Filings. Annual report which provides a comprehensive overview of the company for the past year. Securities offered to employees pursuant to employee benefit plans. A statement of beneficial ownership of common stock by certain persons. Statement of changes in beneficial ownership of securities. Statement of changes in beneficial … rony camera

Bluebird Bio, Inc. (BLUE) 10-Q Quarterly Report August 2024

Category:Document - SEC

Tags:Bluebird bio sec filings

Bluebird bio sec filings

10,000 Shares in bluebird bio, Inc. (NASDAQ:BLUE) Acquired by …

WebApr 14, 2024 · Balentine LLC lessened its stake in Molson Coors Beverage (NYSE:TAP – Get Rating) by 18.8% during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 16,094 shares of the company’s stock after selling 3,737 shares during the period. Balentine LLC’s holdings in … WebApr 10, 2024 · 10 analysts have issued twelve-month price objectives for bluebird bio's shares. Their BLUE share price forecasts range from $3.00 to $10.00. On average, they expect the company's share price to reach $6.78 in the next year. This suggests a possible upside of 118.6% from the stock's current price.

Bluebird bio sec filings

Did you know?

WebFind the latest SEC Filings data for bluebird bio, Inc. Common Stock (BLUE) at Nasdaq.com. WebAnnual report which provides a comprehensive overview of the company for the past year. Annual Filings. 0001467623-23-000012.pdf. 0001467623-23-000012.rtf. 0001467623-23-000012.xls. EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA View HTML. Feb 17, 2024. 4. Statement of changes in beneficial ownership of securities.

WebPost-effective Amendment to an automatic shelf registration of Form S-3ASR or Form F-3ASR. March 01, 2024. 8-K. Current report filing. February 28, 2024. 4. Statement of Changes in Beneficial Ownership. February 28, 2024. 4. WebAnnual report which provides a comprehensive overview of the company for the past year. Annual Filings. View HTML. 0000950170-23-004757.rtf. 0000950170-23-004757.xls. 0000950170-23-004757.pdf. 02/27/23. 4. Statement …

WebApr 14, 2024 · Cookson Peirce & Co. Inc. purchased a new position in bluebird bio, Inc. (NASDAQ:BLUE – Get Rating) during the 4th quarter, according to its most recent filing … WebApr 5, 2024 · bluebird bio is pursuing curative gene therapies to give patients and their families more bluebird days. With a dedicated focus on severe genetic diseases, …

WebAug 4, 2024 · Inside Bluebird Bio, Inc.'s 10-Q Quarterly Report: Financial - Expense Highlight. The decrease of $18.3 million was primarily due to the following: $25.3 million of decreased employee compensation, benefit, and other headcount-related expenses, which is primarily driven by a decrease of $9.1 million in stock-based compensation expense …

rony cherenfantWebChief Strategy and Financial Officer. bluebird bio is a pioneering gene and cell therapy company focused on severe genetic diseases and cancer, including sickle cell disease, β-thalassemia ... rony coiffure frameriesWebMar 29, 2024 · Bluebird Bio, Inc. (BLUE) SEC Filing 8-K Material Event for the period ending Friday, March 24, 2024. ... SEC Filings. BLUE Valuations. Intrinsic Value. Financial Stability. Financial Ratios. Insider Trades. Manager Portfolios. Notifications. BLUE Annual Reports. 10-K Annual Report March 2024 10-K Annual Report March 2024 10-K Annual … rony coiffureWeb10 rows · Mar 29, 2024 · SEC Filing Keyword Search Group 3,4,5 Annual Filings Current Reports Mergers & Acquisitions ... Sarah Alspach joined the flock in September 2024 as Chief … rony chaves guia profetica 2022WebMay 21, 2024 · On May 21, 2024, bluebird bio, Inc. (“bluebird”) issued a press release to announce that it received a positive opinion recommending marketing authorization from … rony chickenWebAug 4, 2024 · Inside Bluebird Bio, Inc.'s 10-Q Quarterly Report: Financial - Expense Highlight. The decrease of $18.3 million was primarily due to the following: $25.3 million … rony cohenWebApr 11, 2024 · Open Statement of changes in beneficial ownership of securities in DOC file. Open Statement of changes in beneficial ownership of securities in PDF file. Open Statement of changes in beneficial ownership of securities in XLS file. 144. Non-EDGAR filing submitted by "insiders" prior to intended sale of restricted stock. rony colin haiti